A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Kronos Bio Inc’s current trading price is -45.90% away from its 52-week high, while its distance from the 52-week low is 33.16%. The stock’s price range for this time frame has been between $0.65 and $1.60. The trading volume of the company’s shares in the Healthcare reached around 9.58 million for the day, which was evidently higher than the average daily volume of 0.54 million over the last three months.
Kronos Bio Inc had a pretty favorable run when it comes to the market performance.
How Financial Performance Impacts Market Capitalization
Kronos Bio Inc (KRON) has experienced a quarterly decline of -9.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.77M and boasts a workforce of 10 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How KRON’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for KRON stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.26.
KRON Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -8.89% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -11.11%. Over the past 30 days, the price of KRON has fallen by 21.87%. And in the last five days, it has surged by 28.90%.
